A fast and robust dual-label nonradioactive oligonucleotide ligation assay for detection of factor V Leiden

Thrombosis and Haemostasis

Volumn 78, Issue 4, 1997, Pages 1234-1236

  Chakravarty, Anders ^a   Hansen, Torben Stiig ^a   Hørder, Mogens ^a   Kristensen, Søren Risom ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; EUROPIUM; LANTHANIDE; OLIGONUCLEOTIDE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; SAMARIUM;

ARTICLE; AUTOMATION; CONTROLLED STUDY; DNA DETERMINATION; DNA TEMPLATE; FLUORESCENCE; GENE MUTATION; GENOTYPE; HUMAN; METHODOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030657797     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657720     Document Type: Article

References (19)

1. Dahlbäck B. The protein C anticoagulant system: Inherited defects as basis for venous thrombosis. Thromb Res 1995; 1: 1-43.
2. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by a poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
3. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
4. Alhenc Gelas M, Gandrille S, Aubry M-L, Emmerich J, Fiessinger J, Aiach M. Unexplained thrombosis and factor V Leiden mutation. Lancet 1994; 344: 555-6.
5. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (Activated protein C resistance). Blood 1995; 85: 1504-8.
6. Soubrier F, Fery I, Verdy E, René MN, Varsat B, Visvikis S, Siest G. The frequency of the factor V gene R506Q mutation varies between regions of France. Nouv Rev Fr Hematol 1995; 37: 175.
7. Rees DC, Cox M, Clegg JB. World distribution of factor V leiden. Lancet 1995; 346: 1133-4.
8. 506-Factor V. Blood 1995; 85: 3405-11.
9. Cumming AM, Tai RC, Fildes S, Yoong A, Keeney S, Hay CRM. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995; 90: 725-7.
10. Ehrenforth S, Radtke KP, Scharrer I. Acquired activated protein C resistance in patients with lupus anticoagulant. Thromb Haemost 1995; 74: 797-8.
11. Trossaërt M, Conard J, Horellou MH, Elalamy I, Samama MM. The modified APC resistance test in the presence of factor V deficient plasma can be used in patients without oral anticoagulant. Thromb Haemost 1996; 75: 521-2.
12. Kirschbaum. NE, Foster PA. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein resistance. Thromb Haemost 1995; 74: 874-8.
13. Beauchamp N, Daly MA, Cooper PC, Preston FE, Peake IR. Rapid two-stage PCR for detecting factor V G1691A mutation. Lancet 1994; 344: 694-5.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
15. Ridker PM, Hennekens CH, Lindpaintner K, Meir J, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for blood coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 1995; 322: 912-7.
16. Landegren U, Kaiser R, Sanders J, Hood L. A ligase-mediated gene detection technique. Science 1988; 241: 1077-80.
17. Samiotaki M, Kwiatowski M, Parik J, Landegren U. Dual-color detection of DNA sequence variants by ligase-mediated analysis. Genomics 1994; 20: 238-42.
18. Zotz BJ, Maruhn-Debowski B, Scharf E. Mutation in the gene coding for coagulation factor V and resistance to activated protein C: Detection of the genetic mutation by oligonucleotide ligation assay using a semiautomated system. Thromb Haemost 1996; 76: 53-5.
19. Benson JM, Phillips DJ, Holloway BP, Evatt BL, Craig Hooper W. Oligonucleotide ligation assay for detection of the factor V mutation (Arg506→Gln) causing protein C resistance. Thromb Res 1996; 83: 87-96.